Literature DB >> 21765648

Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.

Vaneet K Sharma1, Paul Vouros, James Glick.   

Abstract

In the past decade, cell free DNA, or circulating cell free DNA, or cell free circulating DNA, isolated from body fluids such as plasma/serum/urine has emerged as an important tool for clinical diagnostics. The molecular biology of circulating cell free DNA is poorly understood but there is currently an increased effort to understand the origin, mechanism of its circulation, and sensitive characterization for the development of diagnostic applications. There has been considerable progress towards these goals using real time polymerase chain reaction technique (rt-PCR). More recently, new attempts to incorporate mass spectrometric techniques to develop accurate and highly sensitive high-throughput clinical diagnostic tests have been reported. This review focuses on the methods to isolate circulating cell free DNA from body fluids, their quantitative analysis and mass spectrometry based characterization in evolving applications as prenatal and cancer diagnostic tools.

Entities:  

Year:  2011        PMID: 21765648      PMCID: PMC3134299          DOI: 10.1016/j.ijms.2010.10.003

Source DB:  PubMed          Journal:  Int J Mass Spectrom        ISSN: 1387-3806            Impact factor:   1.986


  120 in total

1.  Preimplantation genetic diagnosis.

Authors:  F A Flinter
Journal:  BMJ       Date:  2001-04-28

2.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

3.  Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.

Authors:  Ying Li; Kirstin Finning; Geoff Daniels; Sinuhe Hahn; Xiaoyan Zhong; Wolfgang Holzgreve
Journal:  Prenat Diagn       Date:  2008-03       Impact factor: 3.050

4.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

5.  Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma.

Authors:  Ying Li; Edoardo Di Naro; Angeloantonio Vitucci; Bernhard Zimmermann; Wolfgang Holzgreve; Sinuhe Hahn
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

6.  Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.

Authors:  Chunming Ding
Journal:  Methods Mol Biol       Date:  2008

7.  Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer.

Authors:  Annalisa Altimari; Antonia D'Errico Grigioni; Elisa Benedettini; Elena Gabusi; Riccardo Schiavina; Antonio Martinelli; Antonio Maria Morselli-Labate; Giuseppe Martorana; Walter Franco Grigioni; Michelangelo Fiorentino
Journal:  Am J Clin Pathol       Date:  2008-05       Impact factor: 2.493

8.  Chorionic villus sampling versus early amniocentesis.

Authors:  D Gurwitz
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

9.  Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

Authors:  Aparna A Kamat; Anil K Sood; Dianne Dang; David M Gershenson; Joe L Simpson; Farideh Z Bischoff
Journal:  Ann N Y Acad Sci       Date:  2006-09       Impact factor: 5.691

10.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

View more
  19 in total

Review 1.  Recent technical and biological development in the analysis of biomarker N-deoxyguanosine-C8-4-aminobiphenyl.

Authors:  Zhidan Chen; Yuesheng Zhang; Paul Vouros
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-04-24       Impact factor: 3.205

Review 2.  Characterizing the Cancer Genome in Blood.

Authors:  Sarah-Jane Dawson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

3.  GenoMass software: a tool based on electrospray ionization tandem mass spectrometry for characterization and sequencing of oligonucleotide adducts.

Authors:  Vaneet K Sharma; James Glick; Qing Liao; Chang Shen; Paul Vouros
Journal:  J Mass Spectrom       Date:  2012-04       Impact factor: 1.982

4.  Reversed-phase ion-pair liquid chromatography electrospray ionization tandem mass spectrometry for separation, sequencing and mapping of sites of base modification of isomeric oligonucleotide adducts using monolithic column.

Authors:  Vaneet K Sharma; James Glick; Paul Vouros
Journal:  J Chromatogr A       Date:  2012-05-09       Impact factor: 4.759

Review 5.  The analysis of DNA adducts: the transition from (32)P-postlabeling to mass spectrometry.

Authors:  Joshua J Klaene; Vaneet K Sharma; James Glick; Paul Vouros
Journal:  Cancer Lett       Date:  2012-09-04       Impact factor: 8.679

6.  Detection and Identification of Salmonella enterica, Escherichia coli, and Shigella spp. via PCR-electrospray ionization mass spectrometry: isolate testing and analysis of food samples.

Authors:  Sarah E Pierce; Rebecca L Bell; Rosalee S Hellberg; Chorng-Ming Cheng; Kai-Shun Chen; Donna M Williams-Hill; William B Martin; Marc W Allard
Journal:  Appl Environ Microbiol       Date:  2012-09-21       Impact factor: 4.792

Review 7.  Free DNA--new potential analyte in clinical laboratory diagnostics?

Authors:  Jasenka Wagner
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

8.  Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity?

Authors:  Alyssa W Goldman; Yvonne Burmeister; Konstantin Cesnulevicius; Martha Herbert; Mary Kane; David Lescheid; Timothy McCaffrey; Myron Schultz; Bernd Seilheimer; Alta Smit; Georges St Laurent; Brian Berman
Journal:  Front Physiol       Date:  2015-08-19       Impact factor: 4.566

Review 9.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

10.  Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.

Authors:  Xie Zhang; Xuesong Zhang; Beilei Sun; Hongna Lu; Danping Wang; Xiaogang Yuan; Zhigang Huang
Journal:  Oncol Lett       Date:  2014-08-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.